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Any experiment, process or action in science aiming to be performed 
with high accuracy and precision requires a careful consideration of 
its underlying uncertainties and potential sources of errors.This most 
essential analysis plays a profound role in planning and evaluation of 
the considered processes and is based on established probabilistic 
concepts that quantify expectation values and variances of the 
quantities of interest. 
Naturally, this general framework applies to the planning and 
evaluation of modern radiation therapy, where geometrical and 
dosimetric accuracy and precision are viewed as key performance 
indicators of a treatment. However, so far the analysis of potential 
treatment uncertainties is mostly limited to the PTV margin concept 
where only the aspect of dose coverage of the CTV is explicitly 
addressed at the early planning stage. This approach neglects dose 
uncertainties to other important tissues, because it heuristically 
accounts just for the expectation value of the prescribed tumor dose 
and furthermore does not provide any information about the variances 
or anticipated ‘error bars’ of any relevant treatment quality indicator. 
The key idea of probabilistic treatment planning is to include the 
known or estimated uncertainties of treatment parameters, mostly 
described and modeled by Gaussian probability densities, directly into 
the treatment planning process and automatically generate dose 
distributions whose expectation value is ‘robust’, i.e. not sensitive to 
the anticipated inherent preparation and execution errors of the 
treatment. This requires sacrificing the PTV concept because 
respective safety zones for the dose of the tumor target will be 
automatically generated. Moreover, the method provides a complete 
analysis of the achieved dose patterns in terms of expectation values 
and their respective variances for a final evaluation of a treatment 
plan. 
Besides a general introduction into the topic we will present various 
concepts of probabilistic treatment planning. A specific focus of the 
talk will be on a new approach of probabilistic analytical Gaussian 
dose calculations that allow an efficient application within standard 
inverse planning concepts. This approach is particularly well suited for 
planning of intensity modulated treatments with photon and proton 
beams and naturally can account for any correlation between the 
considered uncertainties. Several examples of respective treatments 
influenced by various sources of uncertainties will be discussed in 
detail. 
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Modern image-guidance systems permit to efficiently correct set-up 
error through rigid translations and, in few cases, rotations of the 
patient. In the case of daily image guidance and disregarding 
contouring uncertainty, the margin that should actually be applied 
should take into account few residual components such as intra-
fraction changes, the uncertainty of the IGRT system in assessing and 
applying the correction and the uncertainty due to the rigidity of the 
correction (here named: residual deformation  error, RDE). 
In several clinical situations, RDE is prevalent and, due to the 
difficulty in individually predicting GTV/CTV deformations during 
treatment, is difficult to manage and to rationally include in a 
properly defined margin. The scenario may also be influenced by 
shrinkage/progression of the tumour that may be counteracted by 
adaptive strategies. Even in this case, the problem of RDE is still there 
in the different phases of the treatment (before/after adaptive 
corrections). 
When the contour of GTV/CTV is available on a large sample of 
fractions, the probability coverage map of the positions of GTV/CTV, 
after rigid correction,  may be precisely assessed for each single 
patient: in the case of daily imaging, it  represents the “true” 
coverage map. The local 3D distances between the planning GTV/CTV 
and the surface corresponding to a large probability coverage (SX%, 
typically S=90-100%) may be calculated to directly assess “margin 
maps” for each specific patient, intrinsically including systematic 
errors. Starting from this map, a pragmatic and robust approach is to 
split GTV/CTV into sectors (for instance, according to a spherical or a 
cylindrical system) and looking to the margin distribution in each 
sector. A first step is to consider the mean value of the local margins 
within each sector, defined here as the “smoothed sector margin” 
(SSM). If expanding GTV/CTV by SSM to take RDE into account in each 
sector, a fraction of the volume included in SX% is not included in the 
corresponding sector PTV (“Out-SSM volume”, OSV): the impact of OSV 
depends on the spread of the local margins with respect to SSM (the 
SD of the variation of sector local margins). In order to take OSV into 
account, it is reasonable to define a cut-off value below which it may 
be disregarded (for instance 95 or 99% of the GTV/CTV sector 
volume): based on this, an additional margin (named “local-noise 
sector margin”, LNSM) may be added to SSM to include the relevant 
fraction of OSV, according to this cut-off. LNSM may be negligible in 
many cases, depending on the noise of the local deformation, on the 
number/type of sectors and on the GTV/CTV volume. Patient specific 
SSM (and, if the case, LNSM) values may be pooled in a population 
analysis to derive SSMY% (and SSM+LNSMY%) corresponding to those 
values that may guarantee a large (90-100%) fraction of patient to be 
covered.   The method was applied on a sample of 20 patients treated 
for rectal cancer (10 supine and 10 prone in institute A and B 
respectively), considering the motion of the rectum; the analysis was 
repeated for the whole and the second part of the treatment. Rectum 
was split in two halves (cranial-caudal) and each half was split in 4 
equi-spaced sectors, according to a cylindrical segmentation of the 
rectum (in total 8 sectors). SSM corresponding to 90% and 100% 
coverage probability were derived for each sector of each patient; 
then, SSM90% (SSM assuring 90-100% sector coverage in 90% of the 
patients) were derived. For the supine group SSM90% were 
significantly smaller in the second part of the treatment with respect 
to the first one and were in the range 4-7mm. The consistency of SSM 
definition was prospectively confirmed on 20 additional patients 
treated with an adaptive boosting in the last 6 fractions (Figure 1): 
PTV including RDE was adequate for 10 male patients, while was 
slightly insufficient for 2/10 female patients.The suggested method 
can assess population-based margins taking RDE into account; it may 
robustly works especially in the case GTV/CTV or their surrogates may 
be drawn on already available daily in-room CT images.  
 
Figure 1 
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Purpose: Besides the need for consistent dosimetry of proton therapy 
beams worldwide, the measurement of absolute dose for this modality 
is important for a variety of reasons. Ensuring consistency with other 
treatment modalities is particularly important when performing mixed 
treatments such as proton and x-ray therapy as is being applied in 
some hospitals. Consistency with other forms of radiotherapy is evenly 
important for coherent detector perturbation factors and biological 
weighting factors across modalities. 
Methods: The traditional method for measuring the quantity absorbed 
dose according to its definition is calorimetry. No primary standards 
for proton dosimetry currently exist although a number of national 
metrology institutes in Switzerland, Germany, The Netherlands and 
the United Kingdom are working towards such calorimetry-based 
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standards. All past experiments comparing calorimeters and ionization 
chambers in proton beams have concentrated on deriving values of 
the mean energy required to produce and ion pair in dry air, (wair)p. 
While calorimetry is in principle simple, its low sensitivity to 
radiotherapy level doses forms a technical challenge. Apart from that, 
in water calorimetry the main influence factors to be controlled or 
corrected for are the chemical heat defect and heat transfer by 
conduction and convection while in graphite calorimeters controlling 
the rapid heat conduction, inhomogeneity corrections and the dose 
conversion from graphite to water are the main concerns. None of 
these are as well understood and characterized for proton beams as 
for photon beams but a state-of-art overview will be presented. In 
particular for scanned proton beams, these issues have raised new 
challenges that have only recently caught attention and are the 
subject of current research efforts. Also other detectors such as 
alanine and ionization chambers play a role in absolute dosimetry as 
transfer instruments between different reference conditions. For 
these detectors the energy dependence needs to be properly 
understood. 
Results: Limited experimental and theoretical evidence revealed that 
the chemical heat defect in water behaves qualitatively similar in 
proton beams as in photon beams but for some aqueous systems, 
including pure water, it is quantitatively different for high-LET 
protons. In graphite there are some indications that a small heat 
defect may be due to energy storage in lattice defects. Corrections 
for the complex heat transfer patterns in scanned beams have been 
shown to be acceptably small in water calorimeters if the time for 
scanning the irradiation volume is limited to 3-4 minutes. However, 
longer irradiation times may occur for large irradiation volumes and 
corrections and associated uncertainties may become substantial. For 
graphite calorimeters a project has started recently to couple 4D 
Monte Carlo calculated dose distributions with finite element heat 
conduction simulations. Preliminary experiments in static and scanned 
proton pencil beams reveal complex heat flows within the calorimeter 
components and response issues when the pencil beam hits the 
sensing or power dissipating thermistors. While this could be 
overcome by operating graphite calorimeters in iso-thermal mode, the 
scanning speed of most beam delivery systems may require larger 
sampling frequencies than currently employed in the read-out and 
thermal control systems. Concerning alanine as transfer instrument, 
several experimental data have been collected recently improving our 
knowledge of its energy dependence. For ion chambers it has been 
shown that the energy dependence of the water to air stopping power 
ratio and the (wair)p value can be mostly neglected for reference 
dosimetry but not necessarily in the Bragg peak. 
Conclusions: Experimental and theoretical insight relevant to 
absolute proton dosimetry has improved considerably over the past 15 
years but, in particular for scanned proton beams, substantial 
research efforts are still required to get our understanding and the 
dosimetric uncertainty at the same level as for photon beams. 
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The reference absorbed dose to water Dw(zref) in proton and heavier 
charged particle beams is currently determined mostly using the IAEA 
TRS-398 Code of Practice (2000). On-going developments on (a) 
calorimetry, (b) ion chamber perturbation correction factors, pch,Q, 
and (c) mean excitation energies  for electronic stopping powers (I-
value), may affect substantially the reference dosimetry of clinical 
proton beams. Item (a) is discussed by Palmans in the previous paper 
whereas (b) and (c) form the basis of the present contribution. Other 
issues of interest, mostly related to influence quantities like the 
recombination correction in scanned beams, are excluded. 
Calorimetry-based primary standards will in a near future empower 
the use of proton reference qualities and kQ,Qo beam quality factors, 
however current clinical dosimetry is based on the use of 60Co and kQ 
data, where chamber-quality factors Fch,Q=sw-air,Q pch,Q play a key role. 
For Farmer-type chambers, calculations (Palmans, Proc. IAEA 
Dosimetry Symp. 2010, 309) have confirmed that pch,Q≈1 for protons, 
in agreement with current data. This is not the case for recent 60Co 
Monte Carlo (MC) calculations resulting in a dramatic change of pch,Co60 
which, if directly applied at the clinic, would decrease Dw(zref) by up 
to 1.5% for all types of charged particles (including electrons).  
It has been overlooked so far that the ratio of ionization chamber 
calibration coefficients ND,w/NK yields the value of Fch,Co60 through the 
ND,air coefficient, as ND,w/ND,air=(sw-air pch)Co60. Fch,Co60 is henceforth 
referred to as experimental, noting that ND,air includes 60Co k and (1-g) 
corrections from IAEA protocols. Based on current BIPM standards (Kair 
update of 2007), calibration coefficients from the IAEA for a large 
sample of NE-2571 chambers yield agreement within 0.1% between 
the TRS-398 and experimental Fch,Co60, superseding the approximate 1% 
difference between Dw(ND,w) and Dw(NK-ND,air) given in the protocol, 
specifically 0.7% for the NE-2571 chamber. Compared with the 
experimental value of Fch,Co60, the MC data difference of about 1.5% is 
not justified for the use of current BIPM Kair and Dw standards if 
consistency throughout the entire dosimetry chain is sought. 
A diversity of I-values for water, Iw, has triggered investigations on 
their effect in stopping powers for dosimetry, mostly for carbon ions. 
Statistical analysis on existing DRF-based and experimental data 
(Burns and Andreo 2012, ICRU work in progress) yields Iw=78 eV 
(formerly 75 eV), in good agreement with ICRU (2009) interim 
recommendation based on carbon ion measurements . This 4% change 
in Iw would result in a sw-air decrease of about 0.4% and 0.6% for 
protons (and heavier charged particles) and 60Co respectively, of 
minor effect on current kQ values. 
Analyzing the influence of an estimate by Burns (Metrologia 2012, 507) 
for the I-value of graphite, IC=81 eV (formerly 78 eV) is less 
straightforward but it might have important implications. New 
graphite stopping powers would enter into pch,Q calculations yielding 
changes only of the order of a few tenths of a per cent. Of larger 
significance, however, is that a new IC  could affect the BIPM Kair 
standard for 60Co; in this case NK  and ND,air would decrease. This would 
be the worst possible scenario for TRS-398, as it would require an 
increase in Fch,Co60 of the order of 0.7% to agree with the experimental 
value. On the other hand, this would be the most favourable situation 
for MC-based Fch,Q calculations, which using  the new stopping powers 
would agree at a level better than 0.1% with the  60Co experimental 
value. In addition, recalling that  Wair,protons  is determined via the NK-
ND,air formalism in combination with calorimetry (see eq) 
 
  
its value would be affected by the decrease of ND,air (60Co) and sw-air,Q 
(protons), yielding an overall increase in Wair,Q of the order of 1%. This 
change might need a revision of previously derived Wair,Q for protons, 
as they would strictly depend on the Kair standard (NK-ND,air) used for 
their derivation. 
The final combination of the changes mentioned in this possible 
scenario would result in a narrow decrease of the calculated kQ (NE-
2571) for protons of about 0.2%, showing the need for maintaining 
consistency in an analysis that unavoidably must include the complete 
dosimetry chain.  
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Relative dosimetry plays an important role during beam-line 
commissioning, in the collection of data for treatment-planning 
systems (clinical commissioning), for quality assurance and for 
research/development purposes. This presentation reviews the 
dosimetry devices that have been successfully employed in proton 
therapy, such as, ionization chambers (IC), films, scintillating screens, 
semiconductors and their field of application. 
We can recognize two main tasks: 1) relative dosimetry orthogonal to 
the beam direction and 2) relative dosimetry along beam direction.  
Relative dosimetry orthogonal to the beam is used to characterize an 
irradiation broad beam (field) or a pencil beam in case of scanning. 
For the former we are interested to measure the lateral field 
geometry, the position of the field edges, the lateral homogeneity of 
dose distribution and the lateral penumbra. In addition, in case of 
scanning, we are interested in the lateral beam width of individual 
pencil beams. Ionization chambers with very small active volumes 
such as, point-like chambers, are suited for measuring lateral profiles 
including penumbra. Silicon diodes and diamond detectors can also be 
used to measure lateral profiles but,unlike IC, their response is LET, 
dose rate and energy dependent. Scintillating screens and 
radiochromic films can measure 2D dose distribution at high resolution 
but they also suffer from LET and energy dependent responses. 
